Emma Court, Bloomberg

Emma Court

Bloomberg

New York, NY, United States

Contact Emma

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Bloomberg
  • Business Insider
  • Business Insider SG
  • Moneyish
  • The Atlantic
  • Cashay
  • Wall Street Journal
  • New York Post

Past articles by Emma:

U.S. Created a Data Disaster With Its Uneven Covid Response

More than a month into a resurgence of the novel coronavirus that has besieged Sun Belt states, flooded hospitals and strained public-health infrastructure, the U.S. still lacks a complete picture of the on-the-ground reality. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More

WeWork board members are talking about ousting CEO Adam Neumann amid IPO turmoil

WeWork CEO Adam Neumann founded the company and built it to what it is today. But his leadership has also come under fierce criticism. → Read More

Opioid-maker Purdue Pharma’s bankruptcy filing shines a rare light on a system criticized for raising US drug prices

Purdue Pharma owes millions to pharmacy chain CVS, health insurer UnitedHealth, and state health departments. → Read More

The CEO of a startup that sells Viagra online just accused a rival of ripping off his company's website

The design and much of the text are the same, Ro CEO Zachariah Reitano said in a Medium post on Monday. And yes, he took screenshots. → Read More

Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

The poop-testing firm said it hopes to entice an investor to purchase it for its scientific knowledge. It also aims to sell its sole remaining product at CVS. → Read More

Buzzy microbiome startup uBiome just filed for bankruptcy

uBiome filed for bankruptcy on Wednesday. The company took on an $8 million loan that will help it to stay open while it searches for a buyer. → Read More

We talked to the top scientist at $340 billion Johnson & Johnson about its 'transformational' new HIV treatment

"It's like a whole different world if you can do this," J&J Chief Scientific Officer Paul Stoffels said. → Read More

The inside story of how a tiny startup and a controversial Twitter doctor sparked viral internet outrage against CVS

"I don't know that I believe they're acting out of a concern for our access to birth control," one consumer advocate said. → Read More

A 29-year-old exec who worked on 2019's biggest biotech IPO told us the 2 key lessons that made it a success

Cameron Turtle helped lead his first IPO last year, then worked on another in June. The stakes were high. → Read More

Trump is exploring ways to let the US import cheaper prescription drugs from Canada

The goal is lower prices and lower spending for American patients, a top Trump administration official said. → Read More

Investors bet $7.3 billion on AI startups tackling healthcare, more than on any other industry

Artificial intelligence is a powerful tool for a data-rich industry. And startups have seen an opening in healthcare, new data from CB Insights shows. → Read More

The first big clue about how Amazon plans to upend the US healthcare system with PillPack just dropped

The new court filings suggest that businesses like the $70 billion pharmacy chain CVS and $240 billion health insurer UnitedHealth could be at risk. → Read More

3 biotechs that investors should buy next after Pfizer's $11 billion deal for cancer drugmaker Array BioPharma

Several other biotechs are also developing "targeted" cancer drugs that aim to better fight the disease. → Read More

The woman who founded $1 billion biotech Gossamer told us about the 3 jobs that prepared her to be a first-time CEO

Sheila Gujrathi has worked as a doctor, a McKinsey consultant, and at an up-and-coming biotech. Each role prepared her to be CEO in different ways. → Read More

From nurses to surgeons, here’s how much everyone makes in a hospital

The Bureau of Labor Statistics (BLS) provides data on wages and employment in hospitals, from janitors to chief executives. → Read More

From nurses to surgeons, here's how much everyone makes in a hospital

The Bureau of Labor Statistics (BLS) provides data on wages and employment in hospitals, from janitors to chief executives. → Read More

Here's how much the typical healthcare employee makes, from CVS to buzzy biotechs

The typical employee at some biotech companies makes north of $200,000 a year. While at CVS, the median pay is just over $35,000. → Read More

The FDA just approved a new treatment for a devastating disease. The price tag is more than $2 million.

The treatment, called Zolgensma, should work longer than the typical drug, but also has a much higher price tag. → Read More